Takayuki Hamano

10.0k total citations · 1 hit paper
182 papers, 4.5k citations indexed

About

Takayuki Hamano is a scholar working on Nephrology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Takayuki Hamano has authored 182 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Nephrology, 42 papers in Pathology and Forensic Medicine and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Takayuki Hamano's work include Parathyroid Disorders and Treatments (72 papers), Dialysis and Renal Disease Management (60 papers) and Vitamin D Research Studies (34 papers). Takayuki Hamano is often cited by papers focused on Parathyroid Disorders and Treatments (72 papers), Dialysis and Renal Disease Management (60 papers) and Vitamin D Research Studies (34 papers). Takayuki Hamano collaborates with scholars based in Japan, United States and United Kingdom. Takayuki Hamano's co-authors include Yoshitaka Isaka, Ikuto Masakane, Isao Matsui, Naohiko Fujii, Shigeru Nakai, Hiromi Rakugi, Yusuke Sakaguchi, Atsushi Wada, Enyu Imai and Yoshiharu Tsubakihara and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Takayuki Hamano

173 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)

2015 318 citations Ikuto Masakane, Shigeru Nakai et al. Therapeutic Apheresis and Dialysis profile →

Peers

Countries citing papers authored by Takayuki Hamano

Since Specialization

Citations

This map shows the geographic impact of Takayuki Hamano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takayuki Hamano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takayuki Hamano more than expected).

Fields of papers citing papers by Takayuki Hamano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takayuki Hamano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takayuki Hamano. The network helps show where Takayuki Hamano may publish in the future.

Co-authorship network of co-authors of Takayuki Hamano

This figure shows the co-authorship network connecting the top 25 collaborators of Takayuki Hamano. A scholar is included among the top collaborators of Takayuki Hamano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takayuki Hamano. Takayuki Hamano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study 2025 ·Clinical Kidney Journal ·Takahiro Imaizumi, Hirotaka Komaba, Takayuki Hamano, Masaomi Nangaku, Kenta Murotani, Takeshi Hasegawa, Naohiko Fujii, Kosaku Nitta, Yoshitaka Isaka, Takashi Wada, Shoichi Maruyama, Masafumi Fukagawa	3
2	Efficacy and Safety of Phosphate-Lowering Agents for Adult Patients with CKD Requiring Dialysis 2025 ·Clinical Journal of the American Society of Nephrology ·(unknown), Takeshi Hasegawa, Miho Murashima, Hisashi Noma, Hiroki Nishiwaki, Shunsuke Yamada, (unknown), (unknown), Hiroshi Kimura, Masatomo Taniguchi, Takayuki Hamano, Masafumi Fukagawa	2
3	Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females 2025 ·Blood Advances ·Yohei Doi, Takayuki Hamano, Osamu Yamaguchi, Yoshitaka Isaka	5
4	Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials 2024 ·Advances in Therapy ·Takayuki Hamano, Yusuke Yamaguchi, (unknown), (unknown), (unknown), Frank Dellanna, Tadao Akizawa, Jonathan Barratt	2
5	Skin Perfusion Pressure Outperforms Ankle-Brachial Index in Predicting Mortality and Cardiovascular Outcomes in Hemodialysis Patients 2024 ·Journal of Atherosclerosis and Thrombosis ·(unknown), (unknown), (unknown), Kodai Suzuki, (unknown), (unknown), Takayuki Hamano	0
6	The benefit of reduced serum phosphate levels depends on patient characteristics: a nationwide cohort study 2024 ·Clinical Kidney Journal ·Shunsuke Goto, Takayuki Hamano, Hideki Fujii, Masatomo Taniguchi, Masanori Abe, Kosaku Nitta, Shinichi Nishi	0
7	Lower Parathyroid Hormone Levels are Associated With Reduced Fracture Risk in Japanese Patients on Hemodialysis 2024 ·Kidney International Reports ·Hirotaka Komaba, Takahiro Imaizumi, Takayuki Hamano, Naohiko Fujii, Masanori Abe, Norio Hanafusa, Masafumi Fukagawa	5
8	Associations of vitamin D receptor activators and calcimimetics with falls and effect modifications by physical activity: A prospective cohort study on the Japan Dialysis Outcomes and Practice Patterns Study 2024 ·Therapeutic Apheresis and Dialysis ·Miho Murashima, Ryohei Yamamoto, Eiichiro Kanda, Noriaki Kurita, Hisashi Noma, Takayuki Hamano, Masafumi Fukagawa	1
9	Associations of calcium, phosphate and intact parathyroid hormone levels with mortality, residual kidney function and technical failure among patients on peritoneal dialysis 2023 ·Clinical Kidney Journal ·Miho Murashima, Naohiko Fujii, Shunsuke Goto, Takeshi Hasegawa, Masanori Abe, Norio Hanafusa, Masafumi Fukagawa, Takayuki Hamano	2
10	Hypocalcemia and cardiovascular mortality in cinacalcet users 2023 ·Nephrology Dialysis Transplantation ·Shunsuke Goto, Takayuki Hamano, Hideki Fujii, Masatomo Taniguchi, Masanori Abe, Kosaku Nitta, Shinichi Nishi	13
11	Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the CREDENCE trial 2023 ·Diabetes Obesity and Metabolism ·Yohei Doi, Takayuki Hamano, Satoshi Yamaguchi, Yusuke Sakaguchi, Jun‐Ya Kaimori, Yoshitaka Isaka	8
12	Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease 2023 ·Nephrology Dialysis Transplantation ·Takeshi Hasegawa, Takahiro Imaizumi, Takayuki Hamano, Kenta Murotani, Naohiko Fujii, Hirotaka Komaba, Masahiko Ando, Shoichi Maruyama, Masaomi Nangaku, Kosaku Nitta, Hideki Hirakata, Yoshitaka Isaka, Takashi Wada, Masafumi Fukagawa	8
13	Predicting ESKD Risk and Time to RRT Initiation Based on Past Slope and Current Value of eGFR: The CKD-JAC Study 2021 ·Journal of the American Society of Nephrology ·Hirotaka Komaba, Takahiro Imaizumi, Takayuki Hamano, Kenta Murotani, Takeshi Hasegawa, Naohiko Fujii, Masafumi Fukagawa	0
14	Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial 2020 ·Journal of Bone and Mineral Research ·Makoto Tsujita, Yohei Doi, Yoshitsugu Obi, Takayuki Hamano, Toshihide Tomosugi, Kenta Futamura, Manabu Okada, Takahisa Hiramitsu, Norihiko Goto, Yoshitaka Isaka, Asami Takeda, Shunji Narumi, Yoshihiko Watarai	11
15	Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients’ conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study 2020 ·BMJ Open Diabetes Research & Care ·Junichi Hoshino, Masanori Abe, Takayuki Hamano, Takeshi Hasegawa, Atsushi Wada, Yoshifumi Ubara, Kenmei Takaichi, Shigeru Nakai, Ikuto Masakane, Kosaku Nitta	9
16	Predictors of outcomes in patients on peritoneal dialysis: A 2-year nationwide cohort study 2019 ·Scientific Reports ·Masanori Abe, Takayuki Hamano, Junichi Hoshino, Atsushi Wada, Shigeru Nakai, Norio Hanafusa, Ikuto Masakane, Kosaku Nitta, Hidetomo Nakamoto	15
17	The association of the difference in hemoglobin levels before and after hemodialysis with the risk of 1-year mortality in patients undergoing hemodialysis. Results from a nationwide cohort study of the Japanese Renal Data Registry 2019 ·PLoS ONE ·Hiroki Nishiwaki, Takeshi Hasegawa, Fumihiko Koiwa, Takayuki Hamano, Ikuto Masakane	2
18	Estimated glomerular filtration rate and the risk–benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial 2017 ·Journal of Internal Medicine ·Yoshitsugu Obi, Kamyar Kalantar‐Zadeh, Ayumi Shintani, Csaba P. Kövesdy, Takayuki Hamano	41
19	Orally Active Vitamin D for Potential Chemoprevention of Posttransplant Malignancy 2012 ·Cancer Prevention Research ·Yoshitsugu Obi, Naotsugu Ichimaru, Takayuki Hamano, Kodo Tomida, Isao Matsui, Naohiko Fujii, Masayoshi Okumi, Jun-Ya Kaimori, Koji Yazawa, Y Kokado, Yoshiharu Tsubakihara, Norio Nonomura, Hiromi Rakugi, Shiro Takahara, Yoshitaka Isaka	14
20	Introduction of DIPS3 (version 2) for Max/MSP 2007 ·Lancaster EPrints (Lancaster University) ·(unknown), (unknown), (unknown), Takayuki Hamano, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact